HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

N1-Methylnicotinamide Improves Hepatic Insulin Sensitivity via Activation of SIRT1 and Inhibition of FOXO1 Acetylation.

AbstractOBJECTIVE:
To explore the effects of N1-methylnicotinamide (MNAM) on insulin resistance and glucose metabolism in obese type 2 diabetes mellitus (T2DM) mice and regulatory mechanisms of the NAD-dependent deacetylase sirtuin-1 (SIRT1)/forkhead box protein O1 (FOXO1) pathway.
METHODS:
Blood glucose and insulin levels were examined in mice. HE and oil red O staining were used to observe the effects of MNAM on liver lipid deposition in ob/ob mice. Real-time PCR and Western blotting were used to detect expression of gluconeogenesis, insulin signaling-related proteins, and SIRT1/FOXO1 pathway-related proteins. L-O2 cells were cultured as a model of insulin resistance, and MNAM and SIRT1 inhibitors were administered in vivo. Residual glucose and insulin signaling-related proteins were detected and the mechanisms associated with the SIRT1/FOXO1 signaling pathway in insulin resistance explored.
RESULTS:
MNAM can effectively reduce levels of fasting blood glucose and insulin, improve liver morphology, and reduce lipid accumulation in obese type 2 diabetes mellitus mice. MNAM also downregulates the key proteins in the gluconeogenesis pathway in the liver, upregulates Sirt1 expression, and reduces acetylation of the FOXO1 protein. In vitro, MNAM could promote the glucose uptake capacity of L-O2 cells induced by palmitic acid (PA), a saturated fatty acid that induces IR in various scenarios, including hepatocytes, improving insulin resistance. As Sirt1 expression was inhibited, the reduction of hepatocyte gluconeogenesis and the regulation of the insulin signaling pathway by MNAM were reversed.
CONCLUSION:
MNAM activates SIRT1 and inhibits acetylation of FOXO1, which in turn regulates insulin sensitivity in type 2 diabetic mice, leading to a reduction of hepatic glucose output and improvement of insulin resistance.
AuthorsJingfan Zhang, Yu Chen, Cong Liu, Ling Li, Ping Li
JournalJournal of diabetes research (J Diabetes Res) Vol. 2020 Pg. 1080152 ( 2020) ISSN: 2314-6753 [Electronic] England
PMID32280711 (Publication Type: Journal Article)
CopyrightCopyright © 2020 Jingfan Zhang et al.
Chemical References
  • Blood Glucose
  • Forkhead Box Protein O1
  • Insulin
  • Niacinamide
  • Sirt1 protein, mouse
  • Sirtuin 1
  • N(1)-methylnicotinamide
Topics
  • Acetylation (drug effects)
  • Animals
  • Blood Glucose (metabolism)
  • Cell Line
  • Diabetes Mellitus, Type 2 (metabolism)
  • Forkhead Box Protein O1 (metabolism)
  • Insulin (blood)
  • Insulin Resistance (physiology)
  • Lipid Metabolism (drug effects)
  • Liver (drug effects, metabolism)
  • Male
  • Mice
  • Niacinamide (analogs & derivatives, pharmacology)
  • Obesity (metabolism)
  • Sirtuin 1 (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: